Form POS AM - Post-Effective amendments for registration statement:
SEC Accession No. 0001079973-25-001464
Filing Date
2025-09-16
Accepted
2025-09-16 16:30:26
Documents
86

Document Format Files

Seq Description Document Type Size
1 POST-EFFECTIVE AMENDMENT NO. 1 cdio_posam.htm   iXBRL POS AM 2492703
2 CONSENT OF PRAGER METIS CPAS LLC. ex23x1.htm EX-23.1 2546
3 GRAPHIC image_008.jpg GRAPHIC 24123
4 GRAPHIC image_009.jpg GRAPHIC 23865
5 GRAPHIC image_010.jpg GRAPHIC 39258
6 GRAPHIC image_011.jpg GRAPHIC 102472
7 GRAPHIC image_012.jpg GRAPHIC 56049
8 GRAPHIC image_013.jpg GRAPHIC 83374
9 GRAPHIC image_014.jpg GRAPHIC 54902
  Complete submission text file 0001079973-25-001464.txt   10166624

Data Files

Seq Description Document Type Size
10 XBRL SCHEMA FILE cdio-20250630.xsd EX-101.SCH 60122
11 XBRL CALCULATION FILE cdio-20250630_cal.xml EX-101.CAL 56960
12 XBRL DEFINITION FILE cdio-20250630_def.xml EX-101.DEF 230478
13 XBRL LABEL FILE cdio-20250630_lab.xml EX-101.LAB 384675
14 XBRL PRESENTATION FILE cdio-20250630_pre.xml EX-101.PRE 334784
88 EXTRACTED XBRL INSTANCE DOCUMENT cdio_posam_htm.xml XML 1658104
Mailing Address 311 W. SUPERIOR STREET SUITE 444 CHICAGO IL 60645
Business Address 311 W. SUPERIOR STREET SUITE 444 CHICAGO IL 60645 855-226-9991
Cardio Diagnostics Holdings, Inc. (Filer) CIK: 0001870144 (see all company filings)

EIN.: 870925574 | State of Incorp.: DE | Fiscal Year End: 1231
Type: POS AM | Act: 33 | File No.: 333-283419 | Film No.: 251317683
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
(CF Office: 03 Life Sciences)